PS1-05: Predicting the Risk of Hyperkalemia in Patients with Kidney Disease Starting Angiotensin-Converting Enzyme Inhibitors

Background and Aims: Angiotensin converting enzyme (ACE) inhibitors are widely used in patients with chronic kidney disease (CKD) because the drugs slow disease progression. But some physicians are reluctant to prescribe ACE inhibitors “or use higher doses” because of concerns about the risk of hype...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Johnson, Eric S, Weinstein, Jessica R, Thorp, Micah L, Platt, Robert W, Petrik, Amanda F, Yang, Xiuhai, Anderson, Sharon, Smith, David H
Format: Artigo
Idioma:Inglês
Publicat: Marshfield Clinic 2010
Matèries:
SELECTED ABSTRACTS - HMORN 2009: Clinical Effectiveness
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2842374/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3121/cmr.8.1.41
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars